(Q28379012)

2

0 references

Y Hirohata

3

0 references

H Shirohara

4

0 references

M Yamamoto

5

0 references

M Otsuki

British Journal of Pharmacology

6

0 references

language of work or name

English

0 references

publication date

April 1996

0 references

published in

0 references

volume

117

0 references

issue

7

0 references

page(s)

1558-64

0 references

cites work

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Quantitative studies of antagonists for 5-hydroxytryptamine

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

On the role of cholecystokinin in pancreatic cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Effect of Diabetes Mellitus on the Regulation of Enzyme Secretion by Isolated Rat Pancreatic Acini

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

The pharmacology of histamine H2-receptor antagonists

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Cholecystokinin antagonists

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Perspectives of CCK antagonists in pancreatic research and clinical use. Part I.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Diabetes in the rat is associated with a reversible postreceptor defect in cholecystokinin action

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

A new and rapid method for the clinical determination of α-amylase activities in human serum and urine. optimal conditions

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Two brain cholecystokinin receptors: implications for behavioral actions

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1909435

Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo

27 November 2018

1 reference

12 December 2020

Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas

1 reference

12 December 2020

Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide

1 reference

12 December 2020

A physiological role for cholecystokinin as a regulator of gastrin secretion

1 reference

12 December 2020

Involvement of endogenous cholecystokinin in the development of acute pancreatitis induced by closed duodenal loop

1 reference

12 December 2020

Characterization of a new cholecystokinin receptor antagonist FK480 in in vitro isolated rat pancreatic acini

1 reference

12 December 2020

Lactic dehydrogenase activity in blood

1 reference

12 December 2020

Role of cholecystokinin in regulation of gastrointestinal motor functions

1 reference

12 December 2020

Cholecystokinin Receptors in the Brain: Characterization and Distribution

1 reference

12 December 2020